These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5119057)

  • 41. [Development and trial of a heterogenous antistaphylococcal gamma-globulin].
    Georgadze IA; Rigvava SA; Bubashvili ME
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):82-4. PubMed ID: 2424198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of antistaphylococcal immunotherapy on the status of various indices of cellular immunity in patients with surgical staphylococcal infections].
    Fedorovskaia EA
    Klin Khir (1962); 1983 Jan; (1):61-2. PubMed ID: 6834719
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical aspects of the use of antistaphylococcal plasma on newborn infants with varying manifestations of staphylococcal infection].
    Ebels IG; Dumesh VI; Vasina EF; Bykov AP; Roĭs MS
    Pediatriia; 1981 Feb; (2):49-50. PubMed ID: 7220193
    [No Abstract]   [Full Text] [Related]  

  • 44. [Studies on staphylococcal infection. I. Anti-alpha hemolysin titer in the sera of rabbits with experimentally induced staphylococcal pneumonia].
    Kadowaki J
    Sapporo Igaku Zasshi; 1966; 30(2):106-11. PubMed ID: 6009023
    [No Abstract]   [Full Text] [Related]  

  • 45. [On the specific anti-inflammatory properties of anti-staphylococcal serum].
    Richou R; Lallouette P; Richou R
    Rev Immunol Ther Antimicrob; 1966; 30(4):307-9. PubMed ID: 5968091
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of staphylococcal infections with a mixed vaccine of Staphylococcus aureus bacterioprotein and its toxoid--analysis of therapeutic effects in 125 cases].
    Gao JX
    Zhonghua Yi Xue Za Zhi; 1982 Jul; 62(7):410-1. PubMed ID: 6816414
    [No Abstract]   [Full Text] [Related]  

  • 47. [Therapy of experimental staphylococcal infection with a hyperimmune antistaphylococcal plasma].
    Snastina TI; Belotskiĭ SM; Filiukova OB
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):34-7. PubMed ID: 6333123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum antistaphylococcal alpha-haemolysin titres in cystic fibrosis.
    Iacocca VF; Barbero GJ
    Arch Dis Child; 1968 Apr; 43(228):220-2. PubMed ID: 5645694
    [No Abstract]   [Full Text] [Related]  

  • 49. [Use of antistaphylococcal plasma and antistaphylococcal immunoglobulin in treatment of staphylococcal sepsis].
    Panko GF
    Khirurgiia (Mosk); 1976 Sep; (9):95-8. PubMed ID: 979012
    [No Abstract]   [Full Text] [Related]  

  • 50. [On the use of antistaphylococcal serum in the course of treatment with antidiphtheric serum. (Clinical contribution)].
    PANERO C
    Riv Clin Pediatr; 1961 Nov; 68():316-23. PubMed ID: 14483516
    [No Abstract]   [Full Text] [Related]  

  • 51. [Immune response of donors during immunization with staphylococcus anatoxin].
    Fedorovskaia EA; Nazarchuk LV
    Vrach Delo; 1989 Feb; (2):70-2. PubMed ID: 2711673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The immunotherapy of staphylococcal infections in young children].
    Balaian LB
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Mar; 43(3):121-7. PubMed ID: 5989850
    [No Abstract]   [Full Text] [Related]  

  • 53. [Changes in immunity after immunization of donors for obtaining antistaphylococcal plasma].
    Smirnova AI; Danilova TN; Nikolaeva LK; Mel'nikova VN; Kaznacheeva AI
    Gematol Transfuziol; 1986 Jan; 31(1):56-60. PubMed ID: 3956974
    [No Abstract]   [Full Text] [Related]  

  • 54. [Production of heterelogous antistaphylococcal antitoxic globulin and its experimental study].
    Shubik IuG; Grachev BN; Shabanova LF; Troshina IuA; Davydova TI
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Sep; 50(9):136-7. PubMed ID: 4789662
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pathogenesis and treatment of post-traumatic staphylococcal osteitis: experimental and clinical studies].
    Zołyński K
    Pol Tyg Lek; 1982 Nov; 37(41-42):1245-6. PubMed ID: 7163074
    [No Abstract]   [Full Text] [Related]  

  • 56. [Antitoxic serum in the treatment of staphylococcal infections].
    Slacálková V; Vacek V
    Cas Lek Cesk; 1965 Oct; 104(42):1141-5. PubMed ID: 5850709
    [No Abstract]   [Full Text] [Related]  

  • 57. [On the problem of treating chronic purulent inflammations of the middle ear of staphylococcal etiology].
    Barulina NV; Levina AA
    Vestn Otorinolaringol; 1967; 29(3):43-6. PubMed ID: 5611859
    [No Abstract]   [Full Text] [Related]  

  • 58. [Experience in the prevention of staphylococcal diseases in maternity homes by immunization of pregnant women with staphylococcal toxoid].
    VOSKRESENSKII BV; DMITRIEVA AI; LEBEDEVA ZI
    Zh Mikrobiol Epidemiol Immunobiol; 1961 Jan; 32():33-9. PubMed ID: 13782156
    [No Abstract]   [Full Text] [Related]  

  • 59. [Sero- and vaccine therapy of staphylococcal infections].
    Toscano F
    G Mal Infett Parassit; 1972 Mar; 24(3):142-52. PubMed ID: 5050678
    [No Abstract]   [Full Text] [Related]  

  • 60. [Peculiarities of the cellular composition of the peripheral blood of donors of antistaphylococcal plasma].
    Demidova NV; Rodina RI; Krokhina MA; Lukovkina EN; Skurkovich SV
    Probl Gematol Pereliv Krovi; 1975 Nov; 20(11):49-51. PubMed ID: 1226386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.